Rōvn Comparable Companies and Multiples
Updated: 2026-07-22, aligned to Rōvn master canon generation 8 (effective 2026-07-21). Transaction facts below were verified against primary sources in May 2026 and remain the latest verified set; re-verify before any external use closer to a round. Purpose: category positioning for diligence. Rōvn is pre-launch with zero revenue, so no Rōvn valuation is computed or published on this page.
Sourcing standard. An earlier draft carried blanket estimate labels and two incorrect transaction claims (Verifiable "acquired by Stripe"; Modio "acquired by HealthStream"). Both are corrected below with primary-source citations. Where a private valuation is not reliably disclosed, it is marked (undisclosed) rather than guessed.
1. Comp Universe (verified funding rounds)
Rōvn intersects three categories: healthcare credentialing and provider-data platforms, identity and verification platforms, and healthcare staffing marketplaces. Axuall is the closest strategic overlap and is treated that way in the competitive landscape (see 10.3); this page covers the comps with verified public transactions.
| Comp | Category | Latest verified round / status | Amount | Valuation | Source |
|---|---|---|---|---|---|
| symplr | Healthcare GRC / credentialing / workforce SaaS | Clearlake acquired 2018; new Clearlake strategic investment Jan 2022 | ~$550M (2018 buyout, third-party); ~$1.6B equity capital access (2022 vehicle) | (undisclosed enterprise value) | Clearlake/PR Newswire 2018; Clearlake 2022 |
| Modio Health | Credentialing CRM (OneView) | Acquired by CHG Healthcare, Oct 2019 (not HealthStream; not 2022) | undisclosed | (undisclosed) | CHG Healthcare; Crunchbase acquisition |
| Verifiable | API-first credentialing / provider data | Independent. Series B, July 2023 (Craft Ventures). $50.1M total raised; not acquired by Stripe | $27M Series B | (undisclosed) | PR Newswire / Series B; TechCrunch |
| CertifyOS (Certify) | Healthcare provider-data / credentialing API | Series B, June 26 2025 (Transformation Capital, w/ General Catalyst, Upfront, SemperVirens) | $40M Series B (~$69M total) | (undisclosed) | Certify / Series B; PR Newswire |
| Medallion | Healthcare provider-network / credentialing | Aug 18 2025 round (Acrew Capital lead; Sequoia/GV/Spark insiders). $130M total raised; ~$50.6M 2024 revenue (Latka) | $43M | (undisclosed) | PR Newswire; MobiHealthNews |
| Andros (fmr CredSimple) | Provider credentialing / CVO (NCQA-certified) | Series B (latest); no disclosed 2024 round. ~$48M-$52M total raised | (round amount undisclosed) | (undisclosed) | PitchBook; CB Insights |
| Persona | Identity verification | Series D, Apr 30 2025 ($200M; Founders Fund + Ribbit) | $200M Series D | $2.0B (prior: $1.5B Series C, Sep 2021) | Persona / Series D; PitchBook |
| Plaid | Financial-data network | Tender offer, Feb 2026 ($8B); secondary Apr 2025 ($6.1B) | $575M (Apr 2025 round) | $8.0B (down from $13.4B 2021 peak) | Crunchbase / $8B tender; TechCrunch / $6.1B |
| Incredible Health | Permanent nursing marketplace | Series B, Aug 2022 (Base10) | $80M Series B (~$97M total) | $1.65B | PR Newswire; TechCrunch |
Notes on the corrections vs. the prior draft: - Verifiable is independent, not a Stripe acquisition. Closest API-credentialing comp; $27M Series B (2023). Any "Stripe acquired Verifiable" claim elsewhere in the package is wrong and should be struck. - Modio was acquired by CHG Healthcare in 2019 for undisclosed terms; there is no public HealthStream transaction at any price. The earlier exit-multiple "precedent" built on that claim is removed. - Medallion, CertifyOS/Certify, and Andros do not publicly disclose valuations; revenue is shown only where a primary source exists.
2. Multiple Distribution by Category
| Category | Range (ARR multiple) | Basis |
|---|---|---|
| Healthcare staffing marketplace | 2-4x | Incredible Health / Vivian / Trusted; commoditizing |
| Healthcare credentialing / provider-data platform | ~8-12x | Medallion / Certify / Andros / Verifiable; strategic, recurring |
| Identity and data networks | high teens to 30x+ | Persona ($2B) / Plaid ($8B); network premium |
| Healthcare GRC PE platform | low single-digit revenue multiple | symplr; mature roll-up |
Multiples for the credentialing-platform band are inferred from disclosed total funding, revenue where reported (for example Medallion's ~$50.6M 2024 revenue against $130M cumulative raised), and stage, not from disclosed post-money valuations, most of which are undisclosed. Treat the 8-12x band as a stage-and-category inference, not a quoted transaction multiple.
3. How Rōvn uses these comparables
Honestly, and not as a valuation shortcut:
- No Rōvn multiple is applied to projected revenue on this page. The prior draft multiplied year-two projections from a since-retired model into a valuation range; that math is withdrawn. Pre-launch, zero-revenue companies do not earn ARR multiples.
- Category positioning. The comps show that the credentialing and provider-data category sustains venture-scale outcomes, that the marketplace band compresses, and that the network premium (Plaid, Persona) is earned by reuse density and switching costs, not claimed.
- Milestone-based fundraising. Round sizing follows the sequence in 02.1 Use of Funds: a YC bridge if accepted, then a post-Demo-Day seed modeled at roughly $5M against actual proof. Terms stay silent until counsel confirms the exemption.
- External use gate. Any external valuation scenario requires a comparables memo with time-stamped sources and explicit risk discounts, per canon. This page is the raw material for that memo, not the memo.
4. Premium and discount drivers vs. the comps
What can earn Rōvn a premium over the credentialing band, once proven:
- Worker-controlled, consent-gated evidence that reuses across employers, with each organization keeping its own decision.
- One Resolution Case per underlying issue, named-human decisions, and signed receipts: an auditable operating loop, not a records product.
- Neutral economics: no placement fee and no shift take rate, so Rōvn can work across hiring channels the marketplaces cannot.
- The delegation and CVO path, which makes verified reuse legally durable rather than a product-level convenience.
- Falsifiable network economics: the second Work Activation must be materially faster and cheaper than the first, or the thesis is wrong.
What discounts Rōvn today:
- Pre-launch: zero revenue, zero signed pilots as verified facts.
- Healthcare sales cycles are long and procurement is conservative.
- Vertical concentration in healthcare.
- First-time-CEO scaling risk.
5. Strategic acquirers (long-term optionality)
| Acquirer | Rationale | Verified comp transaction |
|---|---|---|
| CHG Healthcare | Staffing platform plus credentialing tech | Modio Health, 2019 |
| HealthStream | Add-on to CredentialStream portfolio | CloudCME, 2022 |
| symplr | GRC and workforce roll-up consolidation | Serial acquirer, 2018-2022 |
| Workday / UKG | Healthcare extension to a workforce platform | Workday completed its Paradox acquisition Oct 1, 2025 |
| Oracle Health | Clinical-workforce trust layer adjacent to Cerner | Cerner, 2022 |
Strategic-acquirer optionality is real: CHG, HealthStream, and symplr have all transacted in or adjacent to this category. No exit valuation is modeled here; exit math built on the retired projections is withdrawn.
6. Caveats
- 2026 multiples reflect a partial recovery from the 2022-2023 SaaS compression and a sharp re-rate in identity networks (Plaid fell from $13.4B in 2021 to $6.1B in 2025 before recovering to $8B in 2026). Multiples can drift either direction.
- Healthcare-specific multiples typically carry a discount to generic SaaS for slow adoption and regulatory drag.
- Most credentialing-comp valuations are undisclosed; the 8-12x band is inference, and materially different actual numbers may exist.
- Refresh all transaction data before any round conversation; the verification pass behind this table is dated May 2026.